The estimated Net Worth of W Kent Geer is at least $3.39 Tisíc dollars as of 6 June 2023. Mr. Geer owns over 36,101 units of Novan Inc stock worth over $3,391 and over the last 8 years he sold NOVN stock worth over $0. In addition, he makes $0 as Lead Independent Director at Novan Inc.
W has made over 2 trades of the Novan Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 36,101 units of NOVN stock worth $3,249 on 6 June 2023.
The largest trade he's ever made was exercising 36,101 units of Novan Inc stock on 6 June 2023 worth over $3,249. On average, W trades about 3,736 units every 134 days since 2016. As of 6 June 2023 he still owns at least 37,683 units of Novan Inc stock.
You can see the complete history of Mr. Geer stock trades at the bottom of the page.
W. Kent Geer serves as Lead Independent Director of the Company. Mr. Geer has served as managing director, finance and investor relations for Med1 Ventures, LLC, an early stage medical device development company. Mr. Geer was an audit partner with Ernst & Young LLP from 1989 to 2011. Beginning in 2012, Mr. Geer served as the chairman of the board of directors of PowerSecure International, Inc. until the successful sale of the company in May 2016. Mr. Geer also serves on the board of governors of North Raleigh Christian Academy.
W Geer is 66, he's been the Lead Independent Director of Novan Inc since 2017. There are 3 older and 10 younger executives at Novan Inc. The oldest executive at Novan Inc is Robert Ingram, 77, who is the Independent Director.
W's mailing address filed with the SEC is C/O NOVAN, INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703.
Over the last 8 years, insiders at Novan Inc have traded over $72,487 worth of Novan Inc stock and bought 1,476,993 units worth $9,839,419 . The most active insiders traders include John W Palmour, Robert J Keegan a Life Sciences Holdings Ltd .... On average, Novan Inc executives and independent directors trade stock every 70 days with the average trade being worth of $4,566. The most recent stock trade was executed by Machelle Sanders on 27 June 2023, trading 11,553 units of NOVN stock currently worth $4,737.
novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.
Novan Inc executives and other stock owners filed with the SEC include: